Activation-induced cytidine deaminase and CD38 expression in B-cell chronic lymphocytic leukemia

Clinical Lymphoma and Myeloma

Volumn 6, Issue 3, 2005, Pages 251-252

  Degan, Massimo ^a   Zucchetto, Antonella ^a   Bomben, Riccardo ^a   Dal Bo, Michele ^a   Rupolo, Maurizio ^a   Nanni, Paola ^a   Del Poeta, Giovanni ^b   Gattei, Valter ^a  

^a CENTRO DI RIFERIMENTO ONCOLOGICO   (Italy)

^b UNIVERSITY OF ROME TOR VERGATA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

CD38 ANTIGEN; COMPLEMENTARY DNA; CYTIDINE DEAMINASE; CD38 PROTEIN, HUMAN; IMMUNOGLOBULIN HEAVY CHAIN; MEMBRANE PROTEIN;

ANTIGEN EXPRESSION; B CELL LEUKEMIA; B LYMPHOCYTE; BASE PAIRING; CHRONIC LYMPHATIC LEUKEMIA; CORRELATION ANALYSIS; ENZYME ACTIVATION; ENZYME ACTIVITY; EXON; FLOW CYTOMETRY; GENE MUTATION; GENOME ANALYSIS; GERMINAL CENTER; HISTOGENESIS; HUMAN; INTRON; LETTER; MUTATIONAL ANALYSIS; PHENOTYPE; PROGNOSIS; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA SPLICING; SOMATIC HYPERMUTATION; WILD TYPE; BIOSYNTHESIS; GENE EXPRESSION REGULATION; IMMUNOGLOBULIN VARIABLE REGION; METABOLISM; MUTATION;

ANTIGENS, CD38; CYTIDINE DEAMINASE; GENE EXPRESSION REGULATION, LEUKEMIC; HUMANS; IMMUNOGLOBULIN HEAVY CHAINS; IMMUNOGLOBULIN VARIABLE REGION; LEUKEMIA, B-CELL, CHRONIC; MEMBRANE GLYCOPROTEINS; MUTATION; SOMATIC HYPERMUTATION, IMMUNOGLOBULIN;

EID: 33644874172     PISSN: 15579190     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1557-9190(11)70400-0     Document Type: Letter

References (11)

1. Chiorazzi N, Ferrarini M. B cell chronic lymphocytic leukemia: lesson learned from studies of the B cell antigen receptor. Annu Rev Immunol 2003, 21:841-894.
2. Hamblin TJ, Davis Z, Gardiner A, et al. Unmutated Ig V(H) genes are associated with a more aggressive form of chronic lymphocytic leukemia. Blood 1999; 94:1848-1854.
3. Damle RN, Wasil T, Fais F, et al. Ig V gene mutation status and CD38 expression as novel prognostic indicators in chronic lymphocytic leukemia. Blood 1999; 94:1840-1847.
4. Oppezzo P, Vuillier F, Vasconcelos Y, et al. Chronic lymphocytic leukemia B cells expressing AID display a dissociation between class switch recombination and somatic hypermutation. Blood 2003; 101:4029-4032.
5. McCarthy H, Wierda WG, Barron LL, et al. High expression of activation-induced cytidine deaminase (AID) and splice variants is a distinctive feature of poor-prognosis chronic lymphocytic leukemia. Blood 2003; 101:4903-4908.
6. Albesiano E, Messmer BT, Damle RN, et al. Activation-induced cytidine deaminase in chronic lymphocytic leukemia B cells: expression as multiple forms in a dynamic, variably sized fraction of the clone. Blood 2003; 102:3333-3339.
7. Matutes E, Owusu-Ankomah K, Morilla R, et al. The immunological profile of B cell disorders and proposal of a scoring system for the diagnosis of CLL. Leukemia 1994; 8:1640-1645.
8. Del Poeta G, Maurillo L, Venditti A, et al. Clinical significance of CD38 expression in dironic lymphocytic leukemia. Blood 2001; 98:2633-2639.
9. Cerutti A, Zan H, Kim EC, et al. Ongoing in vivo immunoglobulin class switch DNA recombination in chronic lymphocytic leukemia B cells. J Immunol 2002; 169:6594-6603.
10. Gurrieri C, McGuire P, Zan H, et al. Chronic lymphocytic leukemia B cells undergo somatic hypermutation and intraclonal immunoglobulin V(H)DJ(H) gene diversification. J Exp Med 2002; 196:629-639.
11. Degan M, Bomben R, Dal Bo M, et al. Analysis of IgV gene mutations in B cell chronic lymphocytic leukaemia according to antigen-driven selection identifies subgroups with different prognosis and usage of the canonical somatic hypermutation machinery. Br J Haematol 2004; 126:29-42.